-
provides internal and external leadership for the PhD Program that advances the NHWSN mission, vision, and values. Additionally, the PhD Program Director works closely with the Laney Graduate School (LGS
-
software, databases and interfaces. Works with the entire bioinformatics team to diagnose and fix related issues. Responsible for leading projects and the management and oversight of other team members. With
-
genomics projects of high public health importance, in conjunction with the CDC’s Emerging Infections Program. The Bioinformatics Scientist will have a PhD in Bioinformatics, Computer Science or related
-
that have national and international impact. Conducts program research and prepares operational and statistical reports. May write publishable articles and papers. Serves as a liaison to and works with other
-
commercial value of an invention and markets early stage University-developed technology to industry. Negotiates terms and conditions, including royalties, of licenses with potential licensees. Monitors
-
, works with partners in more than 150 countries to eliminate diseases, ensure access to vaccines and essential medicines, and strengthen health systems to protect populations. Expertise includes neglected
-
; management of equipment, space, and other shared resources, and other duties as assigned. Salary and faculty rank will be commensurate with experience and accomplishments. Eligible candidates will have: a PhD
-
new approaches to business problems and makes recommendations for problem solving through effective decision-making and creative thinking. Directs industry analysis and benchmarking studies. Adjusts
-
SON: Director, Online Learning and Engagement (Academic Leader) - Clinical Track Faculty Appointment
on or leads various school, university, and professional committees, advisory groups, taskforces, or projects as appropriate. Works closely with the Associate Dean for Education, Program/Specialty Directors
-
programs with an NIH-funded T32 training grant in non-malignant hematology · The Aflac Developmental Therapeutics Program offers a wide portfolio of clinical trials from cooperative groups, industry partners